pyrroles has been researched along with Intestinal Perforation in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, YA; Ko, SY; Lee, KE; Park, JC; Park, SY; Seo, MJ; Sim, EH; Yang, YJ | 1 |
| Cerdán-Miguel, J; Cerdán-Santacruz, C; Esteban, F; García-Alonso, M; Jiménez, F; Ortega, M; Santos-Rancaño, R; Sanz, R; Sanz-Ortega, G; Zuloaga, J | 1 |
| Bladé, JS; Boudin, L; Bourgouin, S; de Jauréguiberry, JP; Romeo, É | 1 |
| Bernatsky, S; Curtis, JR; Xie, F; Yun, H | 1 |
| Chen, L; Coe, J; Curtis, JR; Gal-Levy, R; Higginbotham, P; Nowell, WB; O'Hara, K; Sa'adon, R; Safford, M; Willig, J | 1 |
| Breaker, K; Flaig, TW; Kim, FJ; La Rosa, FG; Russ, PD; Schoen, J | 1 |
| Hur, H; Jee, SB; Jeon, HM; Jung, SE; Kim, W; Park, AR | 1 |
| Lolkema, MP; van Hillegersberg, R; Verheul, HM; Voest, EE; Walraven, M; Witteveen, PO | 1 |
| Carroll, AR; Coleman, RL; Sood, AK | 1 |
| Endo, T; Hasegawa, H; Hoshino, Y; Ishii, Y; Kaneko, G; Kitagawa, Y; Mikami, S; Mukai, M; Ochiai, H; Okabayashi, K; Oya, M | 1 |
| Ashikari, A; Kobayashi, H; Kohno, Y; Namitome, R; Nishiyama, T; Saito, S; Yagi, Y | 1 |
2 review(s) available for pyrroles and Intestinal Perforation
| Article | Year |
|---|---|
Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzenesulfonates; Bevacizumab; Endoscopy; Female; Humans; Indoles; Intestinal Perforation; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Radiography; Sorafenib; Sunitinib | 2011 |
Therapeutic advances in women's cancers.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzenesulfonates; Bevacizumab; Cetuximab; ErbB Receptors; Female; Genital Neoplasms, Female; Humans; Indoles; Intestinal Perforation; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Poly(ADP-ribose) Polymerase Inhibitors; Protein-Tyrosine Kinases; PTEN Phosphohydrolase; Pyridines; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sunitinib; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A | 2011 |
10 other study(ies) available for pyrroles and Intestinal Perforation
| Article | Year |
|---|---|
[A case of pneumatosis intestinalis associated with sunitinib treatment for renal cell carcinoma].
Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Administration Schedule; Humans; Indoles; Intestinal Perforation; Kidney Neoplasms; Lung; Male; Pneumatosis Cystoides Intestinalis; Positron-Emission Tomography; Pyrroles; Sunitinib; Tomography, X-Ray Computed | 2013 |
Rectal perforation associated with sunitinib therapy.
Topics: Aged; Angiogenesis Inhibitors; Humans; Indoles; Intestinal Perforation; Male; Pyrroles; Rectal Diseases; Sunitinib | 2013 |
Rectal perforation after two years of treatment with sunitinib for metastatic kidney cancer.
Topics: Angiogenesis Inhibitors; Carcinoma, Renal Cell; Colon, Sigmoid; Humans; Indoles; Intestinal Perforation; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Radiography; Rectum; Retropneumoperitoneum; Sunitinib | 2014 |
Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments.
Topics: Abatacept; Adult; Age Factors; Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Databases, Factual; Diverticulitis; Esophageal Perforation; Female; Gastroesophageal Reflux; Glucocorticoids; Humans; Incidence; Intestinal Perforation; Male; Medicare; Middle Aged; Peptic Ulcer; Piperidines; Prednisone; Proportional Hazards Models; Pyrimidines; Pyrroles; Risk Factors; Rituximab; Tumor Necrosis Factor-alpha; United States | 2016 |
Social media for arthritis-related comparative effectiveness and safety research and the impact of direct-to-consumer advertising.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Comparative Effectiveness Research; Direct-to-Consumer Advertising; Herpes Zoster; Humans; Intestinal Perforation; Natural Language Processing; Piperidines; Pyrimidines; Pyrroles; Social Media | 2017 |
Colonic pneumatosis and intestinal perforations with sunitinib treatment for renal cell carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Female; Humans; Indoles; Intestinal Perforation; Kidney Neoplasms; Pneumatosis Cystoides Intestinalis; Pyrroles; Radiography; Sunitinib | 2009 |
Perforation of the colon by invading recurrent gastrointestinal stromal tumors during sunitinib treatment.
Topics: Aged; Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Perforation; Male; Neoplasm Recurrence, Local; Peritonitis; Piperazines; Pyrimidines; Pyrroles; Sunitinib | 2008 |
Sorafenib: gastrointestinal perforation. Known reactions to VEGF inhibitors.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Benzenesulfonates; Europe; Humans; Indoles; Intestinal Perforation; Pyridines; Pyrroles; Receptors, Vascular Endothelial Growth Factor | 2009 |
Two cases of bowel perforation associated with sunitinib treatment for renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Female; Humans; Indoles; Intestinal Perforation; Kidney Neoplasms; Male; Middle Aged; Peritonitis; Pyrroles; Sunitinib | 2012 |
[Two cases of bowel perforation in patients with metastatic renal cancer treated with a molecularly targeted drug].
Topics: Aged, 80 and over; Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Indoles; Intestinal Perforation; Kidney Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Pyrroles; Sorafenib; Sunitinib | 2012 |